CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2025-06-04 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2024-06-05 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2023-06-06 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +16,532 | 16,532 | ||
| 2022-09-01 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +10,391 | 10,391 | ||
| 2021-06-10 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +6,877 | 6,877 | ||
| 2020-02-10 | Fishman Mark Director | Conversion | +17,007 | 17,007 | ||
| 2020-02-10 | Fishman Mark Director | Conversion · Series A-1 Preferred Stock | −15,768 | 0 | ||
| 2020-02-10 | Fishman Mark Director | Conversion · Series A-2 Preferred Stock | −1,239 | 0 |
Page 1 of 1 · 9 trades